Lei Zhu

ORCID: 0000-0003-1685-7968 · 5 papers in corpus · active 2015-2024

Study types

  • article 3
  • other 1

Condition tags

  • adenomyosis 2
  • endometriosis 1
  • chronic_pelvic_pain 1
article 2024
Cytotoxic T Lymphocytes, Tc17 Cells, Th1 Cells, and ThGM Cells are Increased in the Blood and Ectopic Endometrium of Patients With Adenomyosis
American journal of reproductive immunology (New York, N.Y. : 1989) ·doi:10.1111/aji.13901

PROBLEM: Adenomyosis (AM) is associated with immune response and inflammation. However, the role of T cell subsets in AM development has not been thoroughly understood. METHOD OF STUDY: Patients with focal or diffuse AM were recruited. Ser…

article 2024
[Expert consensus on diagnosis and treatment of chronic pelvic pain].
·doi:10.3760/cma.j.cn112141-20240320-00171
2022
A Computer Tomography Radiomics-based model to Predict Survival of Patients with EGFR‑Mutated Non‑small‑cell Lung Cancer
·doi:10.21203/rs.3.rs-1840484/v1
other 2020
Ginsenoside Rg3 attenuates endometriosis by inhibiting the viability of human ectopic endometrial stromal cells through the nuclear factor-kappaB signaling pathway
Journal of gynecology obstetrics and human reproduction ·doi:10.1016/j.jogoh.2019.101642

OBJECTIVE: To investigate the effects of ginsenoside Rg3 on human ectopic endometriotic stromal cells in vitro. MATERIALS AND METHODS: Ectopic endometrial tissue specimens were obtained from 6 female patients with ovarian endometriosis who…

article 2015
Blocking IL-22, a potential treatment strategy for adenomyosis by inhibiting crosstalk between vascular endothelial and endometrial stromal cells.
American journal of translational research

Our previous work has demonstrated that interleukin-22 (IL-22) enhances the invasiveness of endometrial stromal cells (ESCs) of adenomyosis in an autocrine manner. In the present study, we further investigated whether IL-22 mediated crossta…